相关实验视频

Updated: Jul 1, 2025

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care

Published on: February 16, 2015

多形质母细胞瘤的基因疗法:它可以改变角色吗?

Mohammad Rayati¹, Vahid Mansouri¹, Naser Ahmadbeigi¹

¹Gene Therapy Research Center, Digestive Diseases Research Institute, Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran.

|March 5, 2024

概括

基因疗法为治疗多形质母细胞瘤 (GBM),一种致命的大脑癌症提供了一个有希望的新途径. 这种先进的方法可以克服当前治疗的局限性,并提高患者的存活率.

科学领域:

神经瘤学神经瘤学
癌症基因治疗基因治疗
分子医学是分子医学.

背景情况:

多形质母细胞瘤 (GBM) 是一种具有侵略性的脑癌,治疗选择有限,预后不佳.
目前的治疗方法,包括单克隆抗体 (mAbs) 等向疗法,由于GBM的异质性和药物输送障碍 (血-脑和瘤-血液障碍) 而没有显著改善生存率.

研究的目的:

审查目前的状态和基因疗法在多形质母细胞瘤 (GBM) 治疗的进展.
探索基因疗法的潜力,作为GBM的新治疗策略,解决现有和新兴治疗方法的局限性.

主要方法:

文献综述最近的基因疗法对GBM的进展.
对基因疗法的独特特性进行分析,这些特性可以克服GBM特定的挑战.
与mAbs.等其他先进疗法相比,评估基因疗法的潜力.

主要成果:

基因疗法在GBM治疗中是一个有前途的前沿,与传统疗法相比,它提供了一种独特的方法.
它的潜力在于克服GBM异质性和药物输送障碍所带来的挑战.
虽然基因疗法仍在发展中,但它有潜力解决甚至更新的先进治疗方法的局限性.

结论:

基因疗法对改善多形质母细胞瘤治疗结果具有显著的前景.
进一步的研究和开发对于充分实现其治疗潜力至关重要.
基因疗法可能为管理这种致命的大脑癌症提供了一个新的范式.

关键词:

在GBMGBMGBMGBMGBM 基因治疗是一种基因疗法.质母细胞瘤 (glioblastoma) 是一个免疫治疗是一种免疫疗法.恶性质质瘤是一种恶性质瘤.病毒载体病毒载体

更多相关视频

Characterization of Functionally Associated miRNAs in Glioblastoma and their Engineering into Artificial Clusters for Gene Therapy

Characterization of Functionally Associated miRNAs in Glioblastoma and their Engineering into Artificial Clusters for Gene Therapy

Published on: October 4, 2019

Stereotactic Adoptive Transfer of Cytotoxic Immune Cells in Murine Models of Orthotopic Human Glioblastoma Multiforme Xenografts

Stereotactic Adoptive Transfer of Cytotoxic Immune Cells in Murine Models of Orthotopic Human Glioblastoma Multiforme Xenografts

Published on: September 1, 2018

相关概念视频

Gene Therapy

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...